Iron homeostasis in heart transplant recipients randomized to ferric derisomaltose or placebo

INTRODUCTION: The randomized IronIC trial evaluated the effect of intravenous ferric derisomaltose on physical capacity in iron‐deficient, maintenance heart transplant (HTx) recipients. Iron deficiency was defined as in heart failure with high cut‐points for ferritin to compensate for inflammation....

Descripción completa

Detalles Bibliográficos
Autores principales: Brautaset Englund, Kristine V., Østby, Charlotte M., Broch, Kaspar, Ueland, Thor, Aukrust, Pål, Gude, Einar, Andreassen, Arne K., Gullestad, Lars
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9541327/
https://www.ncbi.nlm.nih.gov/pubmed/35532871
http://dx.doi.org/10.1111/ctr.14695

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9541327/
https://www.ncbi.nlm.nih.gov/pubmed/35532871
http://dx.doi.org/10.1111/ctr.14695

Ejemplares similares